GleamWall
中文EN

A AGILENT TECHNOLOGIES, INC.

Laboratory Analytical Instruments · NYSE · SEC CIK 1090872 · Fiscal year ends 10/31

Financial factors as of 2026-07-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.6%
TTM net income YoY18.0%
TTM EPS YoY18.5%
Revenue 3-yr CAGR1.8%
Net income 3-yr CAGR8.3%

Margins

Gross margin53.8%
Operating margin22.2%
Net margin19.5%
FCF margin17.2%
EBITDA margin25.9%

Returns

ROE21.0%
ROA11.0%
ROIC (approx.)16.0%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets47.3%
Debt / equity0.54x
Current ratio2.05x
Interest coverage15.46x

Cash quality & payout

Operating cash flow / net income1.12x
Accruals ratio-1.3%
Payout ratio19.9%
Capex / revenue4.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-07-312026Q22026-04-302026Q12026-01-312025Q4*2025-10-312025Q32025-07-312025Q22025-04-302025Q12025-01-312024Q4*2024-10-31
Income statement
Revenue$1.88B$1.83B$1.80B$1.86B$1.74B$1.67B$1.68B$1.70B
Cost of revenue$836.00M$845.00M$852.00M$871.00M$850.00M$802.00M$782.00M$785.00M
Gross profit$1.04B$990.00M$946.00M$990.00M$888.00M$866.00M$899.00M$916.00M
R&D expense$123.00M$126.00M$117.00M$119.00M$111.00M$112.00M$113.00M$111.00M
SG&A expense$475.00M$465.00M$476.00M$428.00M$417.00M$454.00M$410.00M$397.00M
Operating income$444.00M$399.00M$353.00M$443.00M$360.00M$300.00M$376.00M$408.00M
Interest expense$29.00M$25.00M$25.00M$27.00M$28.00M$29.00M$28.00M$32.00M
Pretax income$444.00M$408.00M$364.00M$442.00M$366.00M$260.00M$367.00M$401.00M
Income tax$82.00M$69.00M$59.00M$8.00M$30.00M$45.00M$49.00M$50.00M
Net income$362.00M$339.00M$305.00M$434.00M$336.00M$215.00M$318.00M$351.00M
EBITDA$510.00M$466.00M$420.00M$514.00M$432.00M$373.00M$448.00M$477.00M
EPS (basic)1.281.201.08—1.180.751.12—
EPS (diluted)1.281.201.07—1.180.751.11—
Dividends declared per share0.260.260.260.250.250.250.250.24
Weighted avg. shares (diluted)283.00M283.00M284.00M—285.00M285.00M287.00M—
Balance sheet
Cash & equivalents$1.76B$1.81B$1.76B$1.79B$1.54B$1.49B$1.47B$1.33B
Receivables$1.48B$1.50B$1.52B$1.49B$1.38B$1.37B$1.33B$1.32B
Inventory$1.12B$1.09B$1.06B$1.02B$1.01B$991.00M$997.00M$972.00M
Current assets$4.69B$4.76B$4.62B$4.59B$4.25B$4.21B$4.11B$3.96B
PP&E, net$2.13B$2.10B$2.08B$2.02B$1.97B$1.91B$1.82B$1.78B
Goodwill$5.03B$4.48B$4.48B$4.47B$4.47B$4.47B$4.43B$4.48B
Intangibles$906.00M$407.00M$426.00M$445.00M$469.00M$495.00M$514.00M$547.00M
Total assets$13.97B$13.06B$12.81B$12.73B$12.23B$12.16B$11.91B$11.85B
Current liabilities$2.29B$2.27B$2.23B$2.35B$1.89B$2.01B$1.87B$1.90B
Short-term debt$304.00M$304.00M$304.00M$304.00M$59.00M$146.00M$16.00M$45.00M
Long-term debt$3.65B$3.05B$3.05B$3.05B$3.35B$3.35B$3.35B$3.35B
Total debt$3.95B$3.35B$3.35B$3.35B$3.41B$3.50B$3.36B$3.39B
Total liabilities$6.60B$5.94B$5.91B$5.99B$5.86B$6.02B$5.89B$5.95B
Shareholders' equity$7.36B$7.12B$6.91B$6.74B$6.37B$6.14B$6.03B$5.90B
Net debt$2.19B$1.55B$1.60B$1.56B$1.87B$2.01B$1.89B$2.06B
Shares outstanding281.97M282.22M282.70M283.05M283.59M283.94M285.23M285.19M
Cash flow statement
Operating cash flow$519.00M$277.00M$268.00M$545.00M$362.00M$221.00M$431.00M$481.00M
Capital expenditure$80.00M$76.00M$93.00M$93.00M$103.00M$114.00M$97.00M$93.00M
Free cash flow$439.00M$201.00M$175.00M$452.00M$259.00M$107.00M$334.00M$388.00M
Investing cash flow-$1.03B-$77.00M-$93.00M-$90.00M-$96.00M-$114.00M-$94.00M-$954.00M
Financing cash flow$471.00M-$144.00M-$222.00M-$200.00M-$219.00M-$116.00M-$180.00M$25.00M
Depreciation & amortization$66.00M$67.00M$67.00M$71.00M$72.00M$73.00M$72.00M$69.00M
Stock-based compensation$31.00M$34.00M$41.00M$26.00M$32.00M$30.00M$40.00M$26.00M
Dividends paid$72.00M$72.00M$72.00M$70.00M$71.00M$70.00M$71.00M$68.00M
Share buybacks$78.00M$65.00M$152.00M$85.00M$85.00M$165.00M$90.00M$335.00M

Free plan shows the latest 8 periods; Pro shows all 73 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.